You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Prostate cancer discovery opens door to more tailored treatments
- 2. Prostate cancer, race and the need for tests | Letters
- 3. Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Status: Opinion
- 4. Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
- 5. Revealing propionate metabolism-related genes in glioblastoma and investigating their underlying mechanisms
- 6. Discovery of FOXR2 activation in various brain tumours refines diagnosis to improve care
- 7. IV medication could be taken orally for range of cancer, Alzheimer's treatments
- 8. Solid subtype of adenoid cystic carcinoma of the breast with multiple distant metastases: a case report and literature review
- 9. Development and validation of a preoperative magnetic resonance imaging-based and machine learning model for the noninvasive differentiation of intracranial glioblastoma, primary central nervous system lymphoma and brain metastases: a retrospective analysis
- 10. Three-dimensional gene hubs may promote brain cancer
Last updated at 16:04 GMT
Hot News Makers
Health/Pharma Companies
-
319279.62
-
174094.90
-
136788.40
-
53268.60
-
27323.87
-
21599.33
-
20548.45
-
15082.10
-
10733.62
-
6863.65
Drugs, Treatments, Trials
-
63293.94
-
44414.42
-
28973.37
-
10275.52
-
10117.46
-
6870.42
-
6829.88
-
5763.40
-
5726.93
-
5165.18
Last updated at 15:10 GMT
